COSCIENS Biopharma Operating Income Over Time
| CSCI Stock | 2.68 0.03 1.11% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out COSCIENS Biopharma Performance and COSCIENS Biopharma Correlation. Is there potential for Biotechnology market expansion? Will COSCIENS introduce new products? Factors like these will boost the valuation of COSCIENS Biopharma. Projected growth potential of COSCIENS fundamentally drives upward valuation adjustments. Understanding fair value requires weighing current performance against future potential. All the valuation information about COSCIENS Biopharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (6.54) | Revenue Per Share | Quarterly Revenue Growth 0.176 | Return On Assets | Return On Equity |
Understanding COSCIENS Biopharma requires distinguishing between market price and book value, where the latter reflects COSCIENS's accounting equity. The concept of intrinsic value - what COSCIENS Biopharma's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Market sentiment, economic cycles, and investor behavior can push COSCIENS Biopharma's price substantially above or below its fundamental value.
It's important to distinguish between COSCIENS Biopharma's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding COSCIENS Biopharma should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. In contrast, COSCIENS Biopharma's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.
Cross Equities Operating Income Analysis
Compare COSCIENS Biopharma and related stocks such as Biora Therapeutics, Turnstone Biologics Corp, and CervoMed Operating Income Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CRVO | 613 K | (16.4 M) | (11.8 M) | (7.9 M) | (7.3 M) | (6.4 M) | (14.9 M) | (11.3 M) | (12 M) | (11.6 M) | (16 M) | (24.7 M) | (16 M) | (7.8 M) | (18.2 M) | (16.4 M) | (15.6 M) |
| TVRD | 5.4 M | 5.4 M | 5.4 M | 5.4 M | 5.4 M | 5.4 M | 5.4 M | 5.4 M | 5.4 M | 5.4 M | 5.4 M | (89.1 M) | (87.5 M) | (121.5 M) | (55.8 M) | (50.2 M) | (52.7 M) |
COSCIENS Biopharma and related stocks such as Biora Therapeutics, Turnstone Biologics Corp, and CervoMed Operating Income description
Operating Income is the amount of profit realized from COSCIENS Biopharma operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of COSCIENS Biopharma is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. Earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations.My Equities
My Current Equities and Potential Positions
| COSCIENS Biopharma | CSCI |
Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Business Address | 222 Bay Street, |
| Exchange | NASDAQ Exchange |
null 2.68
Check out COSCIENS Biopharma Performance and COSCIENS Biopharma Correlation. For more detail on how to invest in COSCIENS Stock please use our How to Invest in COSCIENS Biopharma guide.You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.
COSCIENS Biopharma technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.